减重手术靶向阿片类药物处方方案对术后疼痛控制的有效性
单中心前瞻性队列研究纳入1264例减重手术患者,比较BSTOP方案实施前后阿片类药物使用情况。结果显示住院和门诊阿片类药物总用量分别减少36%和57%,住院时间从1.53天降至1.28天。加巴喷丁是BSTOP方案的关键组成部分。
要点
- BSTOP方案使住院阿片类药物总用量减少36%,门诊减少57%。
- BSTOP方案使住院时间从1.53天显著降至1.28天。
- 加巴喷丁是BSTOP方案的关键组分,停用后阿片类药物用量增加。
核心结论
- BSTOP方案显著减少住院和门诊阿片类药物使用并缩短住院时间。
- 加巴喷丁是BSTOP方案的关键组成部分。
研究设计与样本
- 单中心前瞻性队列研究,纳入2019年10月至2021年5月接受减重手术的1264例患者。
- BSTOP方案于2020年7月实施,实施前409例,实施后855例。
主要发现
- 住院阿片类药物总用量减少36%,门诊阿片类药物总用量减少57%。
- 住院时间从1.53天降至1.28天。
- 179例患者接受不含加巴喷丁的BSTOP方案,其麻醉后监护室和住院病房阿片类药物用量高于pre-BSTOP和含加巴喷丁BSTOP患者。
- 不含加巴喷丁BSTOP患者住院和门诊阿片类药物总用量少于pre-BSTOP患者,但多于含加巴喷丁BSTOP患者。
临床怎么用
- 减重手术围术期可采用BSTOP多模式镇痛方案以减少阿片类药物使用。
- 实施BSTOP方案时应包含加巴喷丁以优化阿片类药物减量效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical pain management is a critical component in the success of bariatric procedures. With the opioid epidemic, there have been increased efforts to decrease opioid use. In 2019, the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program developed the BSTOP protocol, a multimodal perioperative pain management regimen to minimize opioid use. The objective of this study is to evaluate the effectiveness of the BSTOP protocol on patients' need for opioid medications during their perioperative care. METHODS: This is a single-institution prospective cohort study on patients who underwent bariatric surgery from 10/2019 to 5/2021. Data was collected on morphine equivalent dose of opioids during different stages of inpatient and outpatient care. BSTOP was implemented on 7/2020. Primary outcomes were total inpatient and outpatient opioid use as well as hospital length of hospital stay (LOS). Gabapentin was removed from the protocol between 10/20/2020 and 12/31/2020 due to side effects; it was re-implemented on 1/1/2021 due to observed spikes in opioid use during its absence. RESULTS: 1264 patients who had bariatric surgery between 10/2019 and 5/2021 were included in the study, with 409 patients before (pre-BSTOP) and 855 patients after BSTOP implementation. There was a 36% reduction in total inpatient opiate use and a 57% reduction in total outpatient opiate use. LOS also significantly decreased, from 1.53 to 1.28 days. 179 patients received BSTOP without gabapentin. These patients used more opioids in the post-anesthesia care unit and on the inpatient floors compared to pre-BSTOP and BSTOP with gabapentin patients. With total inpatient and outpatient opioid use, patients on BSTOP without gabapentin used fewer opioids than those pre-BSTOP. However, those on BSTOP without gabapentin used more opioids than those with gabapentin. CONCLUSION: The BSTOP protocol significantly reduced inpatient and outpatient opioid use as well as LOS. Gabapentin is a crucial component of the BSTOP protocol.
引用
- Seu R, Pereira X, Goriacko P, et al. Effectiveness of Bariatric Surgery Targeting Opioid Prescriptions (BSTOP) protocol on postoperative pain control. Surg Endosc. 2022. PMID: 36167874. doi:10.1007/s00464-022-09646-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。